FDA Issues Revised Draft Guidance on "Off-Label" Communications to Health Care Providers – Expanded Scope, Yet Limitations Remain | Dechert LLP
The FDA issued Revised Draft Guidance addressing communications by drug and device manufacturers about “off-label” uses of approved products. The Revised Draft Guidance...
Source: jdsupra.com